Kenji Shirasaki

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Systemic Lupus Erythematosus

Prostate Cancer

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, Tadashi Watabe, Kazuhiro Ooe, Xiaojie Yin, Hiromitsu Haba, Kenji Shirasaki, Hidetoshi Kikunaga, Kazuaki Tsukada, Atsushi Toyoshima, Jens Cardinale, Frederik L Giesel, Koichi Fukase
Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides. International journal of molecular sciences 25 (2) (2024)
Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, Tadashi Watabe, Kazuhiro Ooe, Xiaojie Yin, Hiromitsu Haba, Kenji Shirasaki, Hidetoshi Kikunaga, Kazuaki Tsukada, Atsushi Toyoshima, Jens Cardinale, Frederik L Giesel, Koichi Fukase
Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides. International journal of molecular sciences 25 (2) (2024)
Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, Tadashi Watabe, Kazuhiro Ooe, Xiaojie Yin, Hiromitsu Haba, Kenji Shirasaki, Hidetoshi Kikunaga, Kazuaki Tsukada, Atsushi Toyoshima, Jens Cardinale, Frederik L Giesel, Koichi Fukase
Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides. International journal of molecular sciences 25 (2) (2024)
Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, Tadashi Watabe, Kazuhiro Ooe, Xiaojie Yin, Hiromitsu Haba, Kenji Shirasaki, Hidetoshi Kikunaga, Kazuaki Tsukada, Atsushi Toyoshima, Jens Cardinale, Frederik L Giesel, Koichi Fukase
Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides. International journal of molecular sciences 25 (2) (2024)
Kenji Shirasaki, Mitsuie Nagai, Masahiko Nakase, Chihiro Tabata, Ayaki Sunaga, Tsuyoshi Yaita, Tomoo Yamamura
Sr(ii) extraction by crown ether in HFC: entropy driven mechanism through H 2 PFTOUD. RSC advances 12 (41) (2022)